Towards systemic sclerosis and away from primary biliary cirrhosis: The case of PTPN22

Autoimmunity Highlights

Volumn 3, Issue 1, 2012, Pages 1-9

  Smyk, Daniel S ^a   Mytilinaiou, Maria G ^a   Milkiewicz, Piotr ^b   Rigopoulou, Eirini I ^c   Invernizzi, Pietro ^d,e   Bogdanos, Dimitrios P ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c UNIVERSITY OF THESSALY   (Greece)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Autoimmunity; Bile ducts; Cholestasis; Immunology; Liver; Rheumatology

Indexed keywords

FC RECEPTOR; FC RECEPTOR LIKE 3; HLA DR ANTIGEN; HLA DR11 ANTIGEN; HLA DR13 ANTIGEN; HLA DR8 ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 12P35; INTERLEUKIN 12RB2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; STAT4 PROTEIN; UNCLASSIFIED DRUG;

BANK1 GENE; CXCR5 GENE; DQA1 GENE; DQA2 GENE; DQB1 GENE; DR11 GENE; DR8 GENE; DRB1 GENE; ENZYME ACTIVITY; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IL12A GENE; IL12RB GENE; IL23R GENE; IMMUNOPATHOGENESIS; IRF5 GENE; MMEL1 GENE; NKFB1 GENE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PTPN22 GENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPIB GENE; STAT4 GENE; SYSTEMIC SCLEROSIS; TNSF4 GENE;

EID: 84858768954     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-011-0023-y     Document Type: Review

References (163)

1. Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353: 1261-1273.
2. Hohenester S, Oude-Elferink RP, Beuers U (2009) Primary biliary cirrhosis. Semin Immunopathol 3: 283-307.
3. Neuberger J (1997) Primary biliary cirrhosis. Lancet 350: 875-879.
4. James OF, Bhopal R, Howel D et al (1999) Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 30: 390-394.
5. Akimoto S, Ishikawa O, Takagi H et al (1998) Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone. J Gastroenterol Hepatol 13: 897-901.
6. Sood S, Gow PJ, Christie JM et al (2004) Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 127: 470-475.
7. Rautiainen H, Salomaa V, Niemela S et al (2007) Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scand J Gastroenterol 42: 1347-1353.
8. Bogdanos DP, Baum H, Vergani D (2003) Antimitochondrial and other autoantibodies. Clin Liver Dis 7: 759-777, vi.
9. Bogdanos DP, Baum H, Vergani D et al (2010) The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Dis Markers 29: 301-311.
10. Bogdanos DP, Vergani D (2006) Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int 26: 633-635.
11. Koutsoumpas A, Mytilinaiou M, Polymeros D et al (2009) Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies. Eur J Gastroenterol Hepatol 21: 1220.
12. Gershwin ME, Mackay IR (1991) Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 100: 822-833.
13. Gershwin ME, Mackay IR (2008) The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 47: 737-745.
14. Jones DE (2007) Pathogenesis of primary biliary cirrhosis. Gut 56: 1615-1624.
15. Mackay IR, Whittingham S, Fida S et al (2000) The peculiar autoimmunity of primary biliary cirrhosis. Immunol Rev 174: 226-237.
16. Shimoda S, Nakamura M, Ishibashi H et al (1995) HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 181: 1835-1845.
17. Shimoda S, Nakamura M, Shigematsu H et al (2000) Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 31: 1212-1216.
18. Shimoda S, van de Water J, Ansari A et al (1998) Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102: 1831-1840.
19. Vergani D, Bogdanos DP (2003) Positive markers in AMA-negative PBC. Am J Gastroenterol 98: 241-243.
20. Bogdanos DP, Vergani D (2006) Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver Int 26(6): 633-635.
21. Bogdanos DP, Invernizzi P, Mackay IR et al (2008) Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 14(21): 3374-3387.
22. Bogdanos DP, Komorowski L (2011) Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta 412: 502-512.
23. Dahnrich C, Pares A, Caballeria L et al (2009) New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem 55: 978-985.
24. Liu H, Norman GL, Shums Z et al (2010) PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35: 436-442.
25. Ma Y, Thomas MG, Okamoto M et al (2002) Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 169: 277-285.
26. Rigopoulou EI, Davies ET, Bogdanos DP et al (2007) Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver Int 27: 1226-1231.
27. Velaga MR, Wilson V, Jennings CE et al (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89: 5862-5865.
28. Invernizzi P, Lleo A, Podda M (2007) Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 27: 161-172.
29. Bogdanos DP, Mieli-Vergani G, Vergani D (2009) Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 29: 241-253.
30. Mytilinaiou MG, Bogdanos DP (2009) Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis. Dig Liver Dis 41: 916 (author reply 916-917).
31. Rigopoulou EI, Bogdanos DP, Liaskos C et al (2007) Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta 380: 118-121.
32. Courvalin JC, Worman HJ (1997) Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Semin Liver Dis 17: 79-90.
33. Invernizzi P, Selmi C, Ranftler C et al (2005) Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 25: 298-310.
34. Szostecki C, Guldner HH, Will H (1997) Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin Liver Dis 17: 71-78.
35. Dubel L, Tanaka A, Leung PS et al (1999) Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 29: 1013-1018.
36. Wu SJ, Yang YH, Tsuneyama K et al (2011) Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology 53: 915-925.
37. Palmer JM, Jones DE, Quinn J et al (1999) Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 30: 21-26.
38. Tsuji K, Watanabe Y, van De Water J et al (1999) Familial primary biliary cirrhosis in Hiroshima. J Autoimmun 13: 171-178.
39. Bogdanos DP, Liaskos C, Pares A et al (2007) Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology 45: 1583 (author reply 1583-1584).
40. Invernizzi P, Podda M, Battezzati PM et al (2001) Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34: 366-372.
41. Nakamura M, Kondo H, Mori T et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45: 118-127.
42. Rigopoulou EI, Davies ET, Pares A et al (2005) Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54: 528-532.
43. Bogdanos DP, Vergani D, Muratori P et al (2004) Specificity of anti-sp100 antibody for primary biliary cirrhosis. Scand J Gastroenterol 39: 405-406 (author reply 407).
44. Bogdanos DP, Liaskos C, Rigopoulou EI et al (2006) Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta 373: 183-184 (author reply 185).
45. Bogdanos DP, Gilbert D, Bianchi I et al (2004) Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. J Autoimmune Dis 1: 4.
46. Invernizzi P, Selmi C, Gershwin ME (2010) Update on primary biliary cirrhosis. Dig Liver Dis 42: 401-408.
47. Selmi C, Invernizzi P, Zuin M et al (2005) Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis 25: 265-280.
48. Selmi C, Invernizzi P, Zuin M et al (2005) Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun 6: 543-556.
49. Smyk D, Cholongitas E, Kriese S et al (2011) Primary biliary cirrhosis: family stories. Autoimmune Dis 2011: 189585.
50. Smyk D, Rigopoulou EI, Baum H et al (2011) Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol.
51. Chuang YH, Ridgway WM, Ueno Y et al (2008) Animal models of primary biliary cirrhosis. Clin Liver Dis 12: 333-347.
52. Hirschfield GM, Gershwin ME (2011) Primary biliary cirrhosis: one disease with many faces. Isr Med Assoc J 13: 55-59.
53. Lleo A, Invernizzi P, Mackay IR et al (2008) Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol 14: 3328-3337.
54. Selmi C, Meda F, Kasangian A et al (2010) Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 7: 1-10.
55. Selmi C, Zuin M, Gershwin ME (2008) The unfinished business of primary biliary cirrhosis. J Hepatol 49: 451-460.
56. Vergani D, Bogdanos DP, Baum H (2004) Unusual suspects in primary biliary cirrhosis. Hepatology 39: 38-41.
57. Bogdanos DP, Pares A, Baum H et al (2004) Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. J Autoimmun 22: 353-362.
58. Bogdanos D, Pusl T, Rust C et al (2008) Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol 49: 466-473.
59. Bogdanos DP, Baum H, Okamoto M et al (2005) Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology 42: 458-465.
60. van de Water J, Ishibashi H, Coppel RL et al (2001) Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology 33: 771-775.
61. Baum H, Bogdanos DP, Vergani D (2001) Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope. J Hepatol 34: 785-787.
62. Bogdanos DP, Baum H, Butler P et al (2003) Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis 35: 801-805.
63. Muratori L, Bogdanos DP, Muratori P et al (2005) Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 3: 595-603.
64. Wen L, Ma Y, Bogdanos DP et al (2001) Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med 1: 379-389.
65. Polymeros D, Bogdanos DP, Day R et al (2006) Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology 131: 85-96.
66. Koutsoumpas A, Polymeros D, Tsiamoulos Z et al (2011) Peculiar antibody reactivity to human connexin 37 and its microbial mimics in patients with Crohn's disease. J Crohns Colitis 5: 101-109.
67. Bogdanos DP, Mieli-Vergani G, Vergani D (2000) Virus, liver and autoimmunity. Dig Liver Dis 32: 440-446.
68. Bogdanos DP, Vergani D (2009) Bacteria and primary biliary cirrhosis. Clin Rev Allergy Immunol 36: 30-39.
69. Bogdanos DP, Smith H, Ma Y et al (2005) A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 12: 217-224.
70. Bogdanos DP, Dalekos GN (2008) Enzymes as target antigens of liver-specific autoimmunity: the case of cytochromes P450s. Curr Med Chem 15: 2285-2292.
71. Bogdanos DP, McFarlane IG (2003) Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol 39: 860-863.
72. Lan RY, Cheng C, Lian ZX et al (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43: 729-737.
73. Bernuzzi F, Fenoglio D, Battaglia F et al (2010) Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun 35: 176-180.
74. Longhi MS, Ma Y, Bogdanos DP et al (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41: 31-37.
75. Longhi MS, Ma Y, Mitry RR et al (2005) Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 25: 63-71.
76. Vergani D, Choudhuri K, Bogdanos DP et al (2002) Pathogenesis of autoimmune hepatitis. Clin Liver Dis 6: 727-737.
77. Vergani D, Longhi MS, Bogdanos DP et al (2009) Autoimmune hepatitis. Semin Immunopathol 31: 421-435.
78. Gershwin ME, Selmi C, Worman HJ et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42: 1194-1202.
79. Hudson M, Rojas-Villarraga A, Coral-Alvarado P et al (2008) Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun 31: 156-159.
80. (2009) EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 51: 237-267.
81. Itoh S, Ichida T, Yoshida T et al (1998) Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 13: 257-265.
82. Lassoued K, Guilly MN, Andre C et al (1988) Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clin Exp Immunol 74: 283-288.
83. Poupon R (2010) Primary biliary cirrhosis: a 2010 update. J Hepatol 52: 745-758.
84. Corpechot C, Carrat F, Poupon R et al (2002) Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 122: 652-658.
85. Milkiewicz P (2008) Liver transplantation in primary biliary cirrhosis. Clin Liver Dis 12: 461-472.
86. Schreuder TC, Hubscher SG, Neuberger J (2009) Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 22: 144-152.
87. Corpechot C, Chretien Y, Chazouilleres O et al (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53: 162-169.
88. Parikh-Patel A, Gold EB, Worman H et al (2001) Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. Hepatology 33: 16-21.
89. Prince MI, Ducker SJ, James OF (2010) Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations. Gut 59: 508-512.
90. Chifflot H, Fautrel B, Sordet C et al (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37: 223-235.
91. Le Guern V, Mahr A, Mouthon L et al (2004) Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology (Oxford) 43: 1129-1137.
92. Radic M, Martinovic Kaliterna D, Radic J (2010) Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis. Neth J Med 68: 348-353.
93. Grossman C, Dovrish Z, Shoenfeld Y et al (2011) Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev 10: 244-247.
94. Mora GF (2009) Systemic sclerosis: environmental factors. J Rheumatol 36: 2383-2396.
95. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35: 35-42.
96. Zenewicz LA, Abraham C, Flavell RA et al (2010) Unraveling the genetics of autoimmunity. Cell 140: 791-797.
97. D'Angelo WA, Fries JF, Masi AT et al (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46: 428-440.
98. Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 84: 359-371.
99. Murray-Lyon IM, Thompson RP, Ansell ID et al (1970) Scleroderma and primary biliary cirrhosis. Br Med J 3: 258-259.
100. Reynolds TB, Denison EK, Frankl HD et al (1971) Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome. Am J Med 50: 302-312.
101. O'Brien ST, Eddy WM, Krawitt EL (1972) Primary biliary cirrhosis associated with scleroderma. Gastroenterology 62: 118-121.
102. Gourh P, Agarwal SK, Divecha D et al (2009) Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum 60: 3794-3806.
103. Watt FE, James OF, Jones DE (2004) Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 97: 397-406.
104. Brzezinska-Kolarz B, Undas A, Dyczek A et al (2001) Reynolds syndrome: the combination of scleroderma and primary biliary cirrhosis. Case report. Pol Arch Med Wewn 105: 231-234.
105. Clarke AK, Galbraith RM, Hamilton EB et al (1978) Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 37: 42-47.
106. Geffroy Y, Colin R, Hemet J et al (1973) Primary biliary cirrhosis and scleroderma. Med Chir Dig 2: 281-286.
107. Goring HD, Panzner M, Lakotta W et al (1998) Coincidence of scleroderma and primary biliary cirrhosis. Results of a systematic study of a dermatologic patient sample. Hautarzt 49: 361-366.
108. Maekawa S, Yano E, Shintani S (1992) A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodies. Ryumachi 32: 515-521.
109. Invernizzi P, Miozzo M, Selmi C et al (2005) X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 175: 575-578.
110. Powell FC, Schroeter AL, Dickson ER (1987) Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 62: 75-82.
111. Sherlock S, Scheuer PJ (1973) The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 289: 674-678.
112. Stadie V, Wohlrab J, Marsch WC (2002) Reynolds syndrome-a rare combination of 2 autoimmune diseases. Med Klin 97: 40-43.
113. Culp KS, Fleming CR, Duffy J et al (1982) Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 57: 365-370.
114. Modena V, Marengo C, Amoroso A et al (1986) Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. Clin Exp Rheumatol 4: 129-134.
115. Selmi C, Mayo MJ, Bach N et al (2004) Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127: 485-492.
116. Invernizzi P, Miozzo M, Battezzati PM et al (2004) Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363: 533-535.
117. Invernizzi P, Pasini S, Selmi C et al (2009) Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 33: 12-16.
118. Miozzo M, Selmi C, Gentilin B et al (2007) Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 46: 456-462.
119. Hirschfield GM, Invernizzi P (2011) Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis 31: 147-156.
120. Invernizzi P (2011) Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving. Hepatology 54: 714-723.
121. Donaldson PT, Baragiotta A, Heneghan MA et al (2006) HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology 44: 667-674.
122. Invernizzi P, Battezzati PM, Crosignani A et al (2003) Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 38: 401-406.
123. Hirschfield GM, Liu X, Xu C et al (2009) Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 360: 2544-2555.
124. Hemminki K, Li X, Sundquist K et al (2009) Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum 60: 2845-2847.
125. Liu X, Invernizzi P, Lu Y et al (2010) Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 42: 658-660.
126. Hirschfield GM, Liu X, Han Y et al (2010) Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet 42: 655-657.
127. Mells GF, Floyd JA, Morley KI et al (2011) Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet 43: 329-332.
128. Tanaka A, Invernizzi P, Ohira H et al (2011) Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort. Tissue Antigens 78: 65-68.
129. Tanaka A, Ohira H, Kikuchi K et al (2011) Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients. Tissue Antigens 77: 239-243.
130. Dieude P, Boileau C, Allanore Y (2011) Immunogenetics of systemic sclerosis. Autoimmun Rev 10: 282-290.
131. Agarwal SK, Reveille JD (2010) The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 22: 133-138.
132. Gourh P, Agarwal SK, Martin E et al (2010) Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J Autoimmun 34: 155-162.
133. Dieude P, Guedj M, Wipff J et al (2009) STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 60: 2472-2479.
134. Lamsyah H, Rueda B, Baassi L et al (2009) Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. Tissue Antigens 74: 228-232.
135. Tsuchiya N, Kawasaki A, Hasegawa M et al (2009) Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann Rheum Dis 68: 1375-1376.
136. Dieude P, Guedj M, Wipff J et al (2009) Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 60: 225-233.
137. Dieude P, Wipff J, Guedj M et al (2009) BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum 60: 3447-3454.
138. Dieude P, Guedj M, Wipff J et al (2008) The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum 58: 2183-2188.
139. Gourh P, Tan FK, Assassi S et al (2006) Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum 54: 3945-3953.
140. Begovich AB, Carlton VE, Honigberg LA et al (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75: 330-337.
141. Cohen S, Dadi H, Shaoul E et al (1999) Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93: 2013-2024.
142. Aarnisalo J, Treszl A, Svec P et al (2008) Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun 31: 13-21.
143. Rieck M, Arechiga A, Onengut-Gumuscu S et al (2007) Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 179: 4704-4710.
144. Dieude P, Garnier S, Michou L et al (2005) Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res Ther 7: R1200-R1207.
145. Michou L, Lasbleiz S, Rat AC et al (2007) Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci USA 104: 1649-1654.
146. Hinks A, Barton A, John S et al (2005) Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52: 1694-1699.
147. Viken MK, Amundsen SS, Kvien TK et al (2005) Association analysis of the 1858C> T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6: 271-273.
148. Kyogoku C, Langefeld CD, Ortmann WA et al (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75: 504-507.
149. Orozco G, Sanchez E, Gonzalez-Gay MA et al (2005) Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52: 219-224.
150. Criswell LA, Pfeiffer KA, Lum RF et al (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76: 561-571.
151. Smyth D, Cooper JD, Collins JE et al (2004) Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023.
152. Vandiedonck C, Capdevielle C, Giraud M et al (2006) Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 59: 404-407.
153. LaBerge GS, Bennett DC, Fain PR et al (2008) PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 128: 1757-1762.
154. Skinningsrud B, Husebye ES, Gervin K et al (2008) Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 16: 977-982.
155. Betz RC, Konig K, Flaquer A et al (2008) The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br J Dermatol 158: 389-391.
156. Milkiewicz P, Pache I, Buwaneswaran H et al (2006) The PTPN22 1858T variant is not associated with primary biliary cirrhosis. Tissue Antigens 67: 434-437.
157. Burn GL, Svensson L, Sanchez-Blanco C et al (2011) Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett.
158. Kalabay L, Fekete B, Czirjak L et al (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7: 250-256.
159. Bogdanos DP, Baum H, Gunsar F et al (2004) Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity. Scand J Gastroenterol 39: 981-987.
160. Gomez LM, Anaya JM, Martin J (2005) Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol 66: 1242-1247.
161. Lopez-Escamez JA (2010) A variant of PTPN22 gene conferring risk to autoimmune diseases may protect against tuberculosis. J Postgrad Med 56: 242-243.
162. Waisberg M, Tarasenko T, Vickers BK et al (2011) Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice. Proc Natl Acad Sci USA 108: 1122-1127.
163. Chapman SJ, Khor CC, Vannberg FO et al (2006) PTPN22 and invasive bacterial disease. Nat Genet 38: 499-500.